Rare diseases: A public health priority

Rarity is an attribute which finds contextual appreciation or criticism. A rare gem could be an object of utmost desire, but a rare genetic mutation which translates into the rare, incurable disease is not. A disease which shows particularly low prevalence as it affects a small number of individuals in a population classifies as a […]

India is not spending enough in the research areas: Praveen Gupta

Shahid Akhter, editor, ETHealthworld spoke to Praveen Gupta, Founder and MD, Premas Life Sciences, Delhi to figure out the trends in genomic applications and research that is fast changing the healthcare industry.

Population differentiation of wheat leaf rust fungus Puccinia triticina in South Asia.

Journal: CURRENT SCIENCE Year: 2017 Author List: Prasad, Pramod, S. C. Bhardwaj, O. P. Gangwar, Subodh Kumar, Hanif Khan, Shrawan Kumar, H. C. Rawal, and T. R. Sharma. Fungal-Population genetics URL: http://www.currentscience.ac.in/Volumes/112/10/2073.pdf

प्रीमास, इनेसलडीएक्स ने वितरण करार पर हस्ताक्षर किए

नई दिल्ली, 22 जनवरी (आईएएनएस)| प्रीमास लाइफ साइंसेस प्राइवेट लिमिटेड और इनेसलडीएक्स इंक ने सोमवार को एक विशेष वितरण समझौते पर हस्ताक्षर किए। इस समझौते का फायदा कैंसर रोगियों को मिलने वाला है। दोनों कंपनियों की इस वाणिज्यिक साझेदारी से सेल मल्टीप्लेक्स डायग्नॉस्टिक्स द्वारा ठोस ट्यूमर कार्सिनोमा के लिए सेल को शक्ति मिलेगी। इससे अब […]

प्रीमास, इनेसलडीएक्स ने वितरण करार पर हस्ताक्षर किए

नई दिल्ली, 22 जनवरी (आईएएनएस)| प्रीमास लाइफ साइंसेस प्राइवेट लिमिटेड और इनेसलडीएक्स इंक ने सोमवार को एक विशेष वितरण समझौते पर हस्ताक्षर किए। इस समझौते का फायदा कैंसर रोगियों को मिलने वाला है। दोनों कंपनियों की इस वाणिज्यिक साझेदारी से सेल मल्टीप्लेक्स डायग्नॉस्टिक्स द्वारा ठोस ट्यूमर कार्सिनोमा के लिए सेल को शक्ति मिलेगी। इससे अब […]

Press release on Premas – IncellDx Sign Distribution Agreement

It follows the successful study at AIIMS Institute utilising IncellDx’s (3Dx) investigational molecular assay Premas Life Sciences and IncellDx have signed an exclusive distribution agreement. Included in the deal are IncellDx’s patented single-cell assays for quantifying PD-L1 on tumour cells and immune cell subtypes; patented single-cell assay for HPV E6/E7 mRNA detection in cervical samples; […]

Press release on Premas – IncellDx Sign Distribution Agreement

It follows the successful study at AIIMS Institute utilising IncellDx’s (3Dx) investigational molecular assay Premas Life Sciences and IncellDx have signed an exclusive distribution agreement. Included in the deal are IncellDx’s patented single-cell assays for quantifying PD-L1 on tumour cells and immune cell subtypes; patented single-cell assay for HPV E6/E7 mRNA detection in cervical samples; […]

Praveen Gupta shares his experience of working with Illumina

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. […]

Super-silenced DNA study hints at new ways to reprogram cells

Newly described stretches of super-silenced DNA reveal a fresh approach to reprogram cell identity to use in regenerative medicine studies and one day in the clinic, according to a study in Molecular Celllast week by investigators from the Perelman School of Medicine at the University of Pennsylvania. “In the past, most labs, including my own, […]

Programming DNA to deliver cancer drugs

DNA has an important job — it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off. UD’s Wilfred Chen Group describes their results in a paper published Monday, March 12 in the […]